Dogwood Therapeutics, Inc (DWTX) vs LeonaBio, Inc. (LONA)

Dogwood Therapeutics, Inc and LeonaBio, Inc. are both Biotechnology companies. Dogwood Therapeutics, Inc and LeonaBio, Inc. are of similar size ($40.9M and $39.8M). Across the 9 metrics below, Dogwood Therapeutics, Inc leads on 6 and LeonaBio, Inc. on 3.

Valuation

Metric DWTX LONA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.66 3.12 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (678.03%) (522.84%) (32.88%)
Free cash flow yield (33.54%) (59.08%) (23.13%)

Profitability

Metric DWTX LONA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (143.45%) (431.39%) (51.96%)
Return on assets (40.68%) (306.05%) (46.06%)
Return on invested capital (41.22%) 0.00% 0.00%

Growth

Metric DWTX LONA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 43.05% 1.98% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DWTX LONA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.89 7.01 4.97
Net debt to EBITDA 0.23 0.87 1.01

Dividend

Metric DWTX LONA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DWTX LONA Biotechnology median
Market cap 39.75m 40.89m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack